Realcan Pharmaceutical Group Co Ltd
SZSE:002589
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Realcan Pharmaceutical Group Co Ltd
SZSE:002589
|
CN |
|
R
|
Rizzo Group AB
STO:RIZZO B
|
SE |
|
Shenzhen Huijie Group Co Ltd
SZSE:002763
|
CN |
Wall Street
Price Targets
Price Targets Summary
Realcan Pharmaceutical Group Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Realcan Pharmaceutical Group Co Ltd's stock price target?
Not Available
Realcan Pharmaceutical Group Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Realcan Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
37%
For the last 13 years the
compound annual growth rate for
Realcan Pharmaceutical Group Co Ltd's revenue is
7%.
The projected
CAGR
for the next 5 years is
37%.
What is Realcan Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
159%
For the last 13 years the
compound annual growth rate for
Realcan Pharmaceutical Group Co Ltd's operating income is
-17%.
The projected
CAGR
for the next 6 years is
159%.
What is Realcan Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
120%
For the last 13 years the
compound annual growth rate for
Realcan Pharmaceutical Group Co Ltd's net income is
-8%.
The projected
CAGR
for the next 5 years is
120%.
